Media Centre
News Article

Public Health Champion – Dr Peter Figueroa

June 14, 2019

In May 2019, Dr J. Peter Figueroa was recognised by the World Health Assembly as a health leader for his substantial contribution to public health in Jamaica, the Caribbean, the Americas and the world, over the past four decades[1].

This achievement reminds us of the integral role Dr Figueroa has played in the Region’s HIV response.  In this PANCAP Feature, we reflect on his ground-breaking work and significant contributions to Public Health.

Development of Primary Health Care in Jamaica

In the 1970s, after gaining his medical degree, Dr Figueroa worked in Jamaica’s Public sector.  He contributed significantly to the movement that developed Primary Health Care in Jamaica, including the introduction of community health aides, in advance of the 1978 Alma Ata Declaration. He was awarded a PhD in 1996 by the London School of Hygiene and Tropical Medicine and has since written or co-authored more than 150 published papers and co-edited three books on a range of public health topics.

Formation of the Junior Doctors’ Association (JDA)

As a young doctor, Dr Figueroa, motivated his colleagues in the Government service to form the Junior Doctors’ Association (JDA), now referred to as the Jamaica Medical Doctors Association (JMDA). As President of the JDA, he provided the leadership necessary to improve health services and conditions of work. Dr Figueroa also co-founded the Caribbean Public Health Association and the Caribbean College of Family Practitioners. In 1986 he earned a United Nations Peace Medal for his service as Vice-chair of the National Committee for the commemoration of the International Year of Peace.

Dr Figueroa’s roles over the years have included Principal Medical Officer – Epidemiology in the Ministry of Health; Chief Medical Officer; Director of the National HIV-STI Programme; Scientific Secretary and Chair of the Caribbean Health Research Council (CHRC); and temporary advisor to WHO on a range of public health topics.

 An integral figure in Jamaica’s HIV response

Dr Figueroa has been instrumental in the HIV response in Jamaica, leading the response from its inception in 1986 until 2008 and transforming it into a highly successful multi-sectoral programme. He led the development of a national surveillance system and the investigation of disease outbreaks and established the Epidemiology Research and Training Unit, which conducted numerous research studies including an HIV vaccine trial.

In his early career, he was one of the few clinicians willing to provide medical care to HIV patients. Dr Figueroa continues to provide medical care for People living with HIV at his current medical practice.  In a recent interview with the WHO he stated, “Many people were afraid back then, but we had a responsibility. We had to deal with it, so I lead the response in HIV for many years”.

Established condom usage as a norm

Dr Figueroa mobilised significant funding, established condom usage as a norm nationally and developed the public access anti-retroviral treatment programme. He also expanded STI services, leading outreach for HIV testing and prevention, resulting in a reduction of HIV prevalence among sex workers from 12 to under 4 percent. In addition, Dr Figueroa has been a member of the UNAIDS scientific expert panel since 2014.


“Health is more than health. It is having a just society. It is having the social conditions in place where persons, particularly the most vulnerable are not left behind” – Dr Figueroa


Beyond HIV

Dr Figueroa’s contribution to public health in the Caribbean goes well beyond his work in HIV. He has provided technical advice to many Caribbean countries and the CARICOM Council on Human and Social Development on a variety of public health issues since the 1980s. He served on the Scientific Advisory Council of the Caribbean Epidemiology Centre and since 1989 has been the Chair of the Caribbean Immunization Managers’ Annual Meeting. He is currently part of the Technical Advisory Group for immunisations conveyed by the Pan American Health Organization (PAHO).

Honorary Professor

The University of the West Indies’ Appointments Committee conferred the title of “Honorary Professor’ in the area of Epidemiology and HIV/AIDS on Dr Figueroa.  He received this honour while serving as Chief, Epidemiology and AIDS at the Ministry of Health in Jamaica.  The honour was presented in recognition of his substantial contribution to academic life through teaching and research[2].   He is currently a Professor of Public Health, Epidemiology and HIV and AIDS at the University of the West Indies, Kingston, Jamaica, where he has developed a doctorate programme in public health.

PANCAP Champion

Dr Figueroa has provided technical expertise to PANCAP since its inception in 2001. He was honoured at the inaugural PANCAP Champions for Change Awards in 2004 for his advocacy and innovation in the Region’s HIV response.  At the 15th Ordinary Meeting of the Regional Coordinating Mechanism (RCM) of PANCAP in 2010, he was selected as the recipient of the PANCAP Award for Excellence for his “substantial contribution to the HIV response”. Professor Figueroa was also Chair of the RCM in 2012 and provided leadership for resource mobilisation for the Region.  He also provided guidance as Chair of the Priority Areas Coordinating Committee (PACC) from its inception until the end of 2013. Dr Figueroa was also a pivotal figure in the development and evaluation of the various versions of the Caribbean Regional Strategic Framework on HIV and AIDS (CRSF).   He is currently the Vice Chair of the PANCAP RCM for the Global Fund Project QRA-H-CARICOM, No. 1122.

Now

Dr Figueroa currently serves as the chair of the Caribbean Immunization Technical Advisory Group, which advises Caribbean Ministers of Health, and as Chair of the Caribbean Certification Committee for Eradication of Poliovirus. Dr Figueroa has also made significant contributions to public health research, with a body of research on a wide range of public health and infectious disease topics.

Awards and recognition

Dr Figueroa has received numerous awards in his country, with accolades such as the Medical Association of Jamaica President’s Award, the Jamaica Public Health Hero Award, the Caribbean Health Research Council Award for outstanding contribution to Public Health and Research in the Caribbean, and the Order of Jamaica.

PANCAP salutes Dr Figueroa on his recent achievement; his expertise, drive and compassion for humanity will continue to inspire the Partnership and generations of public health advocates for years to come.

In an invited comment the Director of PANCAP, Mr. Dereck Springer, described Dr Figueroa as a giant in the field of public health and medicine who provides bold, decisive and insightful leadership to guide the strategic direction of the Partnership.

[1] Pan American Health Organization (PAHO) YouTube Channel:

https://www.youtube.com/watch?time_continue=1&v=jt4nf7CciUo

[2]The University of the West Indies at Mona, Jamaica https://www.mona.uwi.edu/marcom/uwinotebook/entry/1385

WHAT IS PANCAP?

PANCAP is a Caribbean regional partnership of governments, regional civil society organisations, regional institutions and organisations, bilateral and multilateral agencies and contributing donor partners established on 14 February 2001.  PANCAP provides a structured and unified approach to the Caribbean’s response to the HIV epidemic, and coordinates the response through the Caribbean Regional Strategic Framework on HIV and AIDS to maximise efficient use of resources and increase impact, mobilise resources and build the capacity of partners.

What are the Global AIDS Strategy 2021–2026 targets and commitments?

If targets and commitments in the strategy are achieved:

  • The number of people who newly acquire HIV will decrease from 1.7 million in 2019 to less than 370 000 by 2025
  • The number of people dying from AIDS-related illnesses will decrease from 690 000 in 2019 to less than 250 000 in 2025.
  • The goal of eliminating new HIV infections among children will see the number of new HIV infections drop from 150,000 in 2019 to less than 22,000 in 2025.

What are the 95-95-95 Targets for ending AIDS?

  • 95% of People Living with HIV know their HIV status;
  • 95% of people who know their status on treatment; and
  • 95% of people on treatment with suppressed viral loads.

HELPFUL LINKS:

Global AIDS Strategy 2021–2026, End Inequalities, End AIDS
https://pancap.org/pancap-documents/global-aids-strategy-2021-2026-end-inequalities-end-aids/

Caribbean Regional Strategic Framework on HIV and AIDS (CRSF) 2019-2025
https://pancap.org/pancap-documents/caribbean-regional-strategic-framework-2019-2025/